The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early adverse symptoms to predict response to treatment among patients in the I-SPY trial.
 
Amrita Basu
Travel, Accommodations, Expenses - Leidos Health
 
Saumya Umashankar
No Relationships to Disclose
 
Denise Wolf
No Relationships to Disclose
 
Christina Yau
Patents, Royalties, Other Intellectual Property - U.S. Provisional Application No. 63/314,065 (Inst); U.S. Provisional Application No. 63/341,579 (Inst); US Application No. 18/174,191 (Inst)
 
Ritu Roy
No Relationships to Disclose
 
Kathryn Ruddy
Research Funding - Medtronic (I)
Patents, Royalties, Other Intellectual Property - Spouse and Mayo Clinic have filed patents related to the application of artificial intelligence to the electrocardiogram for diagnosis and risk stratification. (I)
 
Anne Blaes
Research Funding - Dompé Farmaceutici
 
Adam Olshen
No Relationships to Disclose
 
Angela DeMichele
Consulting or Advisory Role - Pfizer (I)
Research Funding - Genentech (Inst); Inivata/NeoGenomics (Inst); Novartis (Inst); Pfizer (Inst)
 
Jane Perlmutter
No Relationships to Disclose
 
Douglas Yee
Consulting or Advisory Role - Martell diagnostic
Research Funding - Fusion Pharmaceuticals
 
Nola Hylton
Research Funding - Siemens Healthineers (Inst)
 
Laura van t Veer
Employment - Agendia
Stock and Other Ownership Interests - Agendia; Exai Bio
 
Rebecca Shatsky
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Endeavor BioMedicines; Guardant Health; Lilly; Novartis; Stemline Therapeutics; TEMPUS
Research Funding - AstraZeneca (Inst); Briacell (Inst); Gilead Sciences (Inst); Greenwich LifeSciences (Inst); OBI Pharma (Inst); OnKure (Inst); QuantumLeap Health (Inst); Regor Therapeutics (Inst); Stemline Therapeutics (Inst)
 
Claudine Isaacs
Honoraria - Pfizer
Consulting or Advisory Role - AstraZeneca/MedImmune; Genentech/Roche; Gilead Sciences; Merck; Novartis; Pfizer; Puma Biotechnology; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Elsevier - Editor of Book; McGraw Hill Publishing; UpToDate - Wolters Kluwer - Author of chapters
Travel, Accommodations, Expenses - Pfizer
Other Relationship - Curio/Vaniam Group; Medscape; MJH/PER; Side-Out Foundation
 
Hope Rugo
Honoraria - Chugai Pharma; Mylan/Viatris
Consulting or Advisory Role - Bristol Meyer; Napo Pharmaceuticals; Sanofi
Research Funding - Ambryx (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); Hoffmann-La Roche AG/Genentech, Inc (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Stemline Therapeutics (Inst)
 
Laura Esserman
Consulting or Advisory Role - Blue Cross Blue Shield Association
Research Funding - Moderna Therapeutics (Inst)
Travel, Accommodations, Expenses - Blue Cross Blue Shield Association
(OPTIONAL) Uncompensated Relationships - Quantum Leap Healthcare Collaborative
 
Michelle Melisko
Stock and Other Ownership Interests - Merrimack (I)
Consulting or Advisory Role - Genentech
Speakers' Bureau - AstraZeneca (I); Daiichi Sankyo/Astra Zeneca (I); Gilead Sciences (I)
Research Funding - DAEHWA Pharmaceutical (Inst); OBI Pharma (Inst); Puma Biotechnology (Inst)
Patents, Royalties, Other Intellectual Property - Multiple patents related to immunoliposomal drugs being studied and potentially brought to market by Merrimack (I)
Expert Testimony - GlaxoSmithKline
 
Dawn Hershman
Consulting or Advisory Role - AIM Specialty Health
 
I-SPY Trial Investigators and Patient Advocates
No Relationships to Disclose